-orexant
Drugs that block orexin receptors, used for insomnia.
- Drugs ending in -orexant: 8
- Approved somewhere: 3
- With a US drug page: 3
- Stem
- -orexant
- Class
- Drugs that block orexin receptors, used for insomnia
- Most common targets
- HCRTR1, HCRTR2 (4), HCRTR2 (3), HCRTR1 (2)
Approved and clinical-stage drugs in ChEMBL whose names ending in -orexant, matched by spelling; those with a US drug page link to it.
| Acts on | |||
|---|---|---|---|
| Daridorexant | Approved | HCRTR1, HCRTR2, HCRTR1, HCRTR2 | Orexin receptor antagonist |
| Lemborexant | Approved | HCRTR1, HCRTR2 | Orexin receptor 1 antagonist |
| Suvorexant | Approved | HCRTR1, HCRTR2 | Orexin receptor antagonist |
| Almorexant | Phase 3 | HCRTR1, HCRTR2 | Orexin receptor antagonist |
| Fazamorexant | Phase 3 | — | — |
| Seltorexant | Phase 3 | HCRTR2 | Orexin receptor 2 antagonist |
| Filorexant | Phase 2 | HCRTR1, HCRTR2 | Orexin receptor antagonist |
| Tebitorexant | Phase 2 | — | — |
Stem from WHO, The use of stems in the selection of International Nonproprietary Names (INN) for pharmaceutical substances (2024); description written by Arca. Drugs, stages, targets and mechanisms from ChEMBL (CC BY-SA 3.0). WHO